135 related articles for article (PubMed ID: 21291842)
1. Juvenile idiopathic arthritis presenting with prolonged fever.
Yeh TL; Huang FY; Shyur SD; Chen TL; Lee CS; Huang DT
J Microbiol Immunol Infect; 2010 Jun; 43(3):169-74. PubMed ID: 21291842
[TBL] [Abstract][Full Text] [Related]
2. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.
Nigrovic PA; Mannion M; Prince FH; Zeft A; Rabinovich CE; van Rossum MA; Cortis E; Pardeo M; Miettunen PM; Janow G; Birmingham J; Eggebeen A; Janssen E; Shulman AI; Son MB; Hong S; Jones K; Ilowite NT; Cron RQ; Higgins GC
Arthritis Rheum; 2011 Feb; 63(2):545-55. PubMed ID: 21280009
[TBL] [Abstract][Full Text] [Related]
3. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
[TBL] [Abstract][Full Text] [Related]
4. Juvenile idiopathic arthritis--current and future therapies.
Kahn P
Bull NYU Hosp Jt Dis; 2009; 67(3):291-302. PubMed ID: 19852753
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
[TBL] [Abstract][Full Text] [Related]
6. A pruritic linear urticarial rash, fever, and systemic inflammatory disease in five adolescents: adult-onset still disease or systemic juvenile idiopathic arthritis sine arthritis?
Prendiville JS; Tucker LB; Cabral DA; Crawford RI
Pediatr Dermatol; 2004; 21(5):580-8. PubMed ID: 15461768
[TBL] [Abstract][Full Text] [Related]
7. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis.
Frosch M; Ahlmann M; Vogl T; Wittkowski H; Wulffraat N; Foell D; Roth J
Arthritis Rheum; 2009 Mar; 60(3):883-91. PubMed ID: 19248102
[TBL] [Abstract][Full Text] [Related]
8. The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis.
Riddle R; Ryser CN; Morton AA; Sampson JD; Browne RH; Punaro MG; Gatchel RJ
J Pediatr Psychol; 2006 Apr; 31(3):262-71. PubMed ID: 15872147
[TBL] [Abstract][Full Text] [Related]
9. Comparison of patients with juvenile psoriatic arthritis and nonpsoriatic juvenile idiopathic arthritis: how different are they?
Butbul YA; Tyrrell PN; Schneider R; Dhillon S; Feldman BM; Laxer RM; Saurenmann RK; Spiegel L; Cameron B; Tse SM; Silverman ED
J Rheumatol; 2009 Sep; 36(9):2033-41. PubMed ID: 19648305
[TBL] [Abstract][Full Text] [Related]
10. Juvenile idiopathic arthritis.
Boros C; Whitehead B
Aust Fam Physician; 2010 Sep; 39(9):630-6. PubMed ID: 20877765
[TBL] [Abstract][Full Text] [Related]
11. Juvenile idiopathic arthritis.
Weiss JE; Ilowite NT
Pediatr Clin North Am; 2005 Apr; 52(2):413-42, vi. PubMed ID: 15820374
[TBL] [Abstract][Full Text] [Related]
12. Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment.
Burnett HF; Regier DA; Feldman BM; Miller FA; Ungar WJ
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1382-91. PubMed ID: 22504893
[TBL] [Abstract][Full Text] [Related]
13. Rituximab therapy produced rapid and sustained clinical improvement in a patient with systemic onset juvenile idiopathic arthritis refractory to TNF alpha antagonists.
Feito JG; Pereda CA
J Clin Rheumatol; 2009 Oct; 15(7):363-5. PubMed ID: 20009975
[TBL] [Abstract][Full Text] [Related]
14. Juvenile idiopathic arthritis: a chronic pediatric musculoskeletal condition with significant orofacial manifestations.
Barr T; Carmichael NM; Sándor GK
J Can Dent Assoc; 2008 Nov; 74(9):813-21. PubMed ID: 19000466
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and efficacy of intraarticular steroids (IAS) in juvenile idiopathic arthritis (JIA).
Verma S; Gupta R; Lodha R; Kabra SK
Indian Pediatr; 2009 Mar; 46(3):264-5. PubMed ID: 19346579
[TBL] [Abstract][Full Text] [Related]
16. Juvenile idiopathic arthritis: an update.
Olson JC
WMJ; 2003; 102(7):45-50. PubMed ID: 14711024
[TBL] [Abstract][Full Text] [Related]
17. Juvenile idiopathic arthritis.
Gowdie PJ; Tse SM
Pediatr Clin North Am; 2012 Apr; 59(2):301-27. PubMed ID: 22560572
[TBL] [Abstract][Full Text] [Related]
18. Juvenile idiopathic arthritis.
Borchers AT; Selmi C; Cheema G; Keen CL; Shoenfeld Y; Gershwin ME
Autoimmun Rev; 2006 Apr; 5(4):279-98. PubMed ID: 16697970
[TBL] [Abstract][Full Text] [Related]
19. [Acute bone and joint infections in children: how much attention should be paid to persistent fever during intravenous antibiotic therapy?].
Ceroni D; Regusci M; Pazos J; Dayer R; Kaelin A
Rev Chir Orthop Reparatrice Appar Mot; 2003 May; 89(3):250-6. PubMed ID: 12844049
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of juvenile idiopathic arthritis].
Yokota S; Umebayashi H; Katakura S; Imagawa T; Mori M
Nihon Rinsho; 2005 Jan; 63 Suppl 1():453-8. PubMed ID: 15799398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
